Accelerate Dx 2013 Revenues Down 8 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Accelerate Diagnostics said in a document filed with the US Securities and Exchange Commission on Friday that revenues for 2013 were down 8 percent year over year.

The Tucson, Ariz.-based company did not break out revenues for the fourth quarter but based on previously disclosed financial figures for the first three quarters of the year, revenues for Q4 2013 were down 18 percent year over year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: researchers explore the transfer of host genetic material into viruses, and more.

It's too difficult to correct or retract a flawed scientific paper, researchers write in Nature.

A proposed bill would require NSF to only fund research that's in "the national interest."

Australia's Commonwealth Scientific and Industrial Research Organisation plans to eliminate up to 350 jobs.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.